In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Amyris, Sanofi-Aventis, and non-profits in malaria drug deal

Executive Summary

Sanofi-Aventis, Amyris (synthetic biology for drug and chemical production), the Institute for OneWorld Health (iOWH), and the University of California, Berkeley have agreed to work together on the development, manufacturing, and commercialization of a semisynthetic artemisinin for use in malaria treatments.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Synthesis Technologies, Production Processes
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies